Takeda Pharmaceutical reported cash from operations of $0.80B and free cash flow of $1.14B for the quarter ended Jun 2026, down 46.2% year over year. This cash flow statement covers 31 quarters of results from Dec 2017 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Cash Flow Statement | Dec2017 | Mar2018 | Jun2018 | Sep2018 | Dec2018 | Mar2019 | Jun2019 | Sep2019 | Mar2020 | Jun2020 | Dec2020 | Mar2021 | Jun2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||||||||||||||||||||||||
| Net Income | 1.89B | 1.26B | 1.18B | 0.81B | 0.45B | 0.84B | 0.79B | 0.65B | 1.98B | 0.21B | 0.64B | 0.61B | 1.42B | -0.68B | 0.81B | 0.86B | 1.47B | -2.39B | 0.79B | 0.71B | |||||||||||
| Share-based CompensationStock Comp. | 0.09B | 0.08B | 0.10B | 0.12B | 0.12B | 0.11B | 0.11B | 0.13B | 0.13B | 0.12B | 0.10B | 0.14B | 0.12B | 0.12B | 0.11B | 0.13B | 0.12B | 0.13B | 0.11B | ||||||||||||
| Deferred Taxes | -0.58B | -0.33B | -0.19B | -1.26B | -0.41B | -0.42B | -0.41B | -1.24B | -0.34B | -0.38B | -0.24B | -1.20B | -0.21B | -0.25B | -0.25B | -0.82B | -0.16B | -0.23B | -0.11B | ||||||||||||
| Cash from Discontinued OperationsCash from Discont. Ops | |||||||||||||||||||||||||||||||
| Gains from Sales and DivestituresGains Divest | 0.01B | 0.00B | 0.00B | 0.00B | -0.00B | 0.00B | 0.00B | -0.00B | 0.01B | 0.03B | 0.01B | 0.00B | 0.00B | 0.01B | 0.00B | 0.00B | 0.00B | 0.01B | 0.00B | ||||||||||||
| Asset Writedowns and ImpairmentWritedown | 0.14B | 0.00B | 0.11B | 0.16B | 0.04B | 0.17B | 0.06B | 0.82B | 0.05B | 0.11B | 0.17B | 0.07B | 0.01B | 0.45B | 0.02B | 0.58B | 0.05B | 0.32B | 0.19B | ||||||||||||
| Cash from Restructuring | |||||||||||||||||||||||||||||||
| Change in Working CapitalChange Working Cap. | -1.25B | -1.16B | -1.19B | -1.04B | -1.12B | 0.67B | -0.63B | -0.81B | |||||||||||||||||||||||
| Change in ReceivablesChange Receivables | 0.38B | -0.38B | -0.14B | 0.09B | 0.09B | 0.52B | -0.66B | 0.12B | 0.10B | 0.50B | -0.31B | -0.07B | 0.08B | -0.09B | 0.33B | -0.07B | -0.07B | -0.62B | -0.45B | ||||||||||||
| Change in InventoryChange Inventory | 0.19B | -0.19B | -0.07B | -0.05B | -0.13B | -0.34B | -0.21B | -0.34B | -0.34B | 0.09B | -0.06B | -0.28B | 0.14B | -0.03B | -0.09B | -0.20B | -0.25B | 0.12B | -0.21B | ||||||||||||
| Change in Account PayablesChange Payables | 0.39B | -0.23B | -0.75B | -0.29B | -0.05B | 0.45B | -0.25B | -0.10B | 0.48B | -0.21B | -0.24B | 0.00B | 0.13B | 0.07B | -0.19B | 0.11B | 0.02B | 0.03B | -0.14B | ||||||||||||
| Cash from OperationsCash from Ops. | 3.79B | 1.52B | 1.44B | 0.65B | 5.41B | 2.68B | 0.70B | 0.67B | 4.73B | 0.99B | 1.15B | 1.09B | 5.60B | 2.52B | 1.41B | 1.49B | 6.56B | 2.43B | 1.37B | 0.80B | |||||||||||
| Depreciation, Depletion & Amortization | |||||||||||||||||||||||||||||||
| Depreciation & Amortization (CF)Dep. & Amort. | 1.32B | 1.31B | 1.22B | 3.95B | 1.25B | 1.36B | 1.25B | 4.68B | 1.27B | 1.47B | 1.23B | 4.53B | 1.23B | 1.43B | 1.26B | 4.42B | 1.24B | 1.23B | 1.02B | ||||||||||||
| Investing Activities | |||||||||||||||||||||||||||||||
| Capital ExpendituresCapex | -0.34B | -0.27B | -0.33B | -0.21B | -0.24B | -0.27B | -0.34B | -0.26B | -0.32B | -0.30B | -0.37B | -0.33B | -0.30B | -0.32B | -0.33B | -0.27B | -0.27B | -0.30B | -0.34B | ||||||||||||
| Sales of Property, Plant and EquipmentPP&E (Sale) | 0.03B | 0.00B | 0.00B | 0.00B | -0.00B | 0.00B | 0.06B | 0.00B | 0.00B | -0.06B | 0.00B | 0.04B | 0.04B | 0.00B | 0.00B | 0.01B | |||||||||||||||
| Change in IntangiblesChange Intangibless | -0.72B | -0.11B | -0.43B | -0.61B | -0.12B | -1.69B | -1.63B | -1.98B | -0.20B | -1.51B | -0.52B | -1.91B | -0.08B | -0.53B | -0.19B | -1.48B | -1.16B | -0.32B | -0.31B | ||||||||||||
| Acquisitions | -0.25B | ||||||||||||||||||||||||||||||
| Divestments | 3.83B | 0.02B | 0.02B | 0.00B | 0.00B | 0.00B | 0.02B | 0.02B | 0.06B | 0.01B | 0.19B | 0.20B | 0.22B | 0.02B | 0.19B | 0.07B | |||||||||||||||
| Change in Acquisitions & DivestmentsChange Acquisitions | 0.01B | 0.00B | 0.05B | 0.15B | 0.02B | 0.05B | 0.00B | 0.14B | 0.00B | 0.04B | 0.03B | 0.18B | 0.02B | 0.03B | 0.01B | 0.18B | 0.01B | 0.01B | 0.00B | ||||||||||||
| Cash from Investing ActivitiesCash from Investing | -0.02B | -0.64B | -0.81B | -0.73B | -0.20B | -0.33B | -3.31B | -1.94B | -0.42B | -0.51B | -0.41B | -1.01B | -0.50B | -0.76B | -0.13B | -0.23B | -0.33B | -1.49B | -0.37B | -0.55B | |||||||||||
| Financing Activities | |||||||||||||||||||||||||||||||
| Other financing activitiesOther financing | |||||||||||||||||||||||||||||||
| Cash from Financing ActivitiesCash from Financing | -3.50B | -3.75B | -3.54B | -1.67B | -0.38B | -3.08B | -0.05B | -0.42B | -0.97B | -0.66B | -0.39B | ||||||||||||||||||||
| Debt Issuance and Repayment | |||||||||||||||||||||||||||||||
| Non-Current Debt | 1.39B | -0.07B | -0.34B | -0.03B | 0.28B | 0.30B | 0.18B | 0.06B | -0.30B | -0.06B | 0.06B | -0.18B | 0.05B | 0.04B | -0.12B | 0.08B | 0.13B | -0.61B | -0.22B | ||||||||||||
| Current Debt | 0.00B | ||||||||||||||||||||||||||||||
| Dividend Payments | |||||||||||||||||||||||||||||||
| Dividends Paid - Common and PrefferdDiv Paid (Total) | -0.08B | -1.21B | -1.00B | -0.08B | -0.91B | -0.08B | -0.95B | -0.06B | -0.94B | -0.06B | |||||||||||||||||||||
| Additional items | |||||||||||||||||||||||||||||||
| Exchange Rate EffectFX Effect | 0.23B | 0.03B | 0.19B | 0.17B | 0.07B | -0.07B | -0.00B | 0.11B | 0.03B | -0.02B | 0.07B | ||||||||||||||||||||
| Change in Cash | 3.06B | -2.87B | -2.71B | -1.75B | 1.03B | -0.73B | -1.14B | -1.69B | -0.02B | -0.18B | 1.07B | ||||||||||||||||||||
| Free Cash FlowFCF | 4.13B | 1.80B | 1.44B | 0.98B | 5.62B | 2.91B | 0.97B | 1.01B | 4.99B | 1.31B | 1.45B | 1.46B | 5.93B | 2.82B | 1.73B | 1.82B | 6.83B | 2.70B | 1.67B | 1.14B | |||||||||||
| Net Cash FlowNCF | 0.27B | -2.87B | -2.92B | -1.75B | 4.84B | -0.73B | -2.67B | -1.69B | 3.34B | -0.18B | 0.34B | 0.09B | 5.09B | 1.76B | 1.28B | 1.26B | 6.24B | 0.93B | 1.00B | 0.25B |
Pull Takeda Pharmaceutical's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/statements?ticker=TAK&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/statements"
params = {"ticker": "TAK", "statement": "CF", "frequency": "Quarter", "period": "all", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/statements?ticker=TAK&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY");
const data = await res.json();